<![CDATA[Synergy Pharmaceuticals 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=18835>Thu, 14 May 2026 04:35:55 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Late-Breaking Abstract Session During Digestive Disease Week 2013]]>https://www.newswire.co.kr/newsRead.php?no=695632Tue, 21 May 2013 23:00:00 +0900<![CDATA[Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index]]>https://www.newswire.co.kr/newsRead.php?no=695151Wed, 15 May 2013 09:52:31 +0900<![CDATA[Synergy Pharmaceuticals Reports First Quarter 2013 Financial Results]]>https://www.newswire.co.kr/newsRead.php?no=694400Fri, 10 May 2013 09:43:28 +0900<![CDATA[Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock]]>https://www.newswire.co.kr/newsRead.php?no=690149Wed, 17 Apr 2013 09:48:53 +0900<![CDATA[Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of Common Stock]]>https://www.newswire.co.kr/newsRead.php?no=689181Thu, 11 Apr 2013 10:05:38 +0900<![CDATA[Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock]]>https://www.newswire.co.kr/newsRead.php?no=688953Wed, 10 Apr 2013 09:54:53 +0900<![CDATA[Synergy Pharmaceuticals to Begin Trading on The NASDAQ Global Market]]>https://www.newswire.co.kr/newsRead.php?no=678960Mon, 11 Feb 2013 19:00:00 +0900<![CDATA[Synergy Pharmaceuticals Initiates Multiple Ascending Dose Phase Ib Trial in Healthy Volunteers of SP-333, a Second Generation Guanylate Cyclase C Agonist for the Treatment of Ulcerative Colitis]]>https://www.newswire.co.kr/newsRead.php?no=676455Mon, 28 Jan 2013 19:00:00 +0900<![CDATA[Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals]]>https://www.newswire.co.kr/newsRead.php?no=675130Fri, 18 Jan 2013 08:23:39 +0900<![CDATA[Synergy Pharmaceuticals Announces Approval of Merger With Callisto Pharmaceuticals and Other Actions at Annual Meeting of Stockholders]]>https://www.newswire.co.kr/newsRead.php?no=674622Tue, 15 Jan 2013 19:00:00 +0900<![CDATA[Synergy Announces Positive Results From Plecanatide Phase IIb/III Trial in Patients With Chronic Idiopathic Constipation]]>https://www.newswire.co.kr/newsRead.php?no=672795Wed, 02 Jan 2013 19:00:00 +0900<![CDATA[Synergy Pharmaceuticals Completes Phase I Trial of SP-333, a Second-Generation GC-C Agonist to Treat Gastrointestinal Diseases]]>https://www.newswire.co.kr/newsRead.php?no=672214Fri, 28 Dec 2012 19:00:00 +0900